The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

 

HealthSouth Corp

NYSE: HLS
Last

(U.S.) $40.54

Today's change-0.11 -0.27%
Updated September 2 12:58 PM EDT. Delayed by at least 15 minutes.
 

HealthSouth Corp

NYSE: HLS
Last

(U.S.) $40.54

Today's change-0.11 -0.27%
Updated September 2 12:58 PM EDT. Delayed by at least 15 minutes.

HealthSouth Corp down (U.S.)$0.11

HealthSouth Corp is lower today, dropping (U.S.)$0.11 or 0.27% to (U.S.)$40.54. Shares have lost 4.32% over the last five days, but have gained 5.41% over the last year to date. This security has outperformed the S&P 500 by 6.30% during the last year.

Key company metrics

  • Open(U.S.) $41.00
  • Previous close(U.S.) $40.65
  • High(U.S.) $41.00
  • Low(U.S.) $40.14
  • Bid / Ask(U.S.) $40.52 / (U.S.) $40.56
  • YTD % change+5.41%
  • Volume198,092
  • Average volume (10-day)725,331
  • Average volume (1-month)688,361
  • Average volume (3-month)805,753
  • 52-week range(U.S.) $35.84 to (U.S.) $48.37
  • Beta1.68
  • Trailing P/E22.73×
  • P/E 1 year forward17.95×
  • Forward PEG1.60×
  • Indicated annual dividend(U.S.) $0.92
  • Dividend yield2.27%
  • Trailing EPS(U.S.) $1.78
Updated September 2 12:58 PM EDT. Delayed by at least 15 minutes.

Profit

Net Profit (TTM)
+9.02%

Based on its net profit margin of 9.02%, HealthSouth Corp is among the more effective companies in its industry at turning revenues into bottom line profit.
Company Books

S&P TSX0.23%Sector:HealthcareIndustry:Healthcare Facilities
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q2/2015Q1/2015Q4/2014Q3/2014
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedJun 30, 201506/30/2015Mar 31, 201503/31/2015Dec 31, 201412/31/2014Sep 30, 201409/30/2014
Revenue754729607589
Total other revenue--------
Total revenue754729607589
Gross profit722698577562
Total cost of revenue32313027
Total operating expense634610510475
Selling / general / administrative447434349332
Research & development--------
Depreciation / amortization33322827
Interest expense (income), net operating--------
Unusual expense (income)199120
Other operating expenses, total1041039189
Operating income12011997114
Interest income (expense), net non-operating-31-32-26-28
Gain (loss) on sale of assets--------
Other--------
Income before tax94907488
Income after tax62595566
Income tax, total32301922
Net income43434250
Total adjustments to net income0-2-2-2
Net income before extra. items45433951
Minority interest-17-17-15-15
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items44413849
Inc. avail. to common incl. extra. items43414048
Diluted net income43414452
Dilution adjustment----44
Diluted weighted average shares102101101101
Diluted EPS excluding extraordinary itemsvalue per share0.440.400.410.53
Dividends per sharevalue per share0.210.210.210.21
Diluted normalized EPSvalue per share0.560.450.500.55